Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

The Effect of Budesonide Spray Via Mucosal Atomization Device on the Hypothalamic-Pituitary Axis

NCT01405339 is registered in ClinicalTrials.gov with St. Paul's Hospital, Canada as lead sponsor.

NCT NCT01405339
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01405339 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
The Effect of Budesonide Spray Via Mucosal Atomization Device on the Hypothalamic-Pituitary Axis
Lead sponsor
St. Paul's Hospital, Canada
Phase
Phase 1/2
Overall status
Completed
Start date
August 31, 2011
Completion date
January 31, 2014
Enrollment
20 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

chronic rhinosinusitis